lysophosphatidic acid has been researched along with Pulmonary Fibrosis in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aidinis, V; Antoniou, K; Karampitsakos, T; Matralis, AN; Ntatsoulis, K; Stylianaki, EA; Tsitoura, E; Tzouvelekis, A | 1 |
| Chambers, DC; Fieuw, AM; Ford, P; Hopkins, PM; O'Sullivan, B; Powell, JE; Sinclair, KA; Yerkovich, ST | 1 |
| Dong, S; Li, Y; Mialki, RK; Taleb, SJ; Wei, J; Zhao, J; Zhao, Y | 1 |
| Cong, CC; Guan, L; Li, SQ; Mao, LJ; Zhang, YL; Zhao, JY | 1 |
| Budd, DC; Qian, Y | 1 |
| An, MS; Ding, Q; Feng, R; Li, L; Liu, Y; Tang, N; Wang, S; Wei, W; Wen, J; Zhao, Y | 1 |
| Cheng, J; Wang, Y; Xie, Y; Zong, C | 1 |
| Li, J; Sun, X; Wang, G | 1 |
| Ahluwalia, N; Bain, G; Berdyshev, E; Black, KE; Bronova, I; Castelino, FV; Fontaine, BA; Goulet, L; Knipe, RS; Lagares, D; Natarajan, V; Probst, CK; Shea, BS; Tager, AM | 1 |
| Aoki, Y; Badri, L; Cao, P; Fearon, ER; Lagstein, A; Lama, VN; Manning, CM; Walker, NM | 1 |
| Chun, J; Funke, M; Tager, AM; Xu, Y; Zhao, Z | 1 |
| Alessi, D; Gan, X; Kozasa, T; Offermanns, S; Simon, MI; Sommer, E; Srinivasula, S; Wang, C; Wang, J; Wu, D | 1 |
| Shea, BS; Tager, AM | 1 |
| Blackwell, TS; Campanella, GS; Chun, J; Hart, WK; Karimi-Shah, BA; Kim, ND; LaCamera, P; Luster, AD; Pardo, A; Polosukhin, V; Selman, M; Shea, BS; Tager, AM; Wain, J; Xu, Y; Zhao, Z | 1 |
| Ley, K; Zarbock, A | 1 |
3 review(s) available for lysophosphatidic acid and Pulmonary Fibrosis
| Article | Year |
|---|---|
Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
Topics: Anti-Inflammatory Agents; COVID-19; Dexamethasone; Humans; Lung; Lysophospholipids; Phosphoric Diester Hydrolases; Pulmonary Fibrosis; Respiratory Distress Syndrome; SARS-CoV-2; Signal Transduction | 2021 |
Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
Topics: Animals; Drug Evaluation, Preclinical; Enzyme Inhibitors; Lysophospholipids; Phosphoric Diester Hydrolases; Phosphorous Acids; Pulmonary Fibrosis; Receptors, Lysophosphatidic Acid; Small Molecule Libraries | 2013 |
Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.
Topics: Capillary Permeability; Cell Physiological Phenomena; Epithelial Cells; Fibroblasts; Humans; Lysophospholipids; Pulmonary Alveoli; Pulmonary Fibrosis; Receptors, Lysophosphatidic Acid; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Wound Healing | 2012 |
12 other study(ies) available for lysophosphatidic acid and Pulmonary Fibrosis
| Article | Year |
|---|---|
The autotaxin-lysophosphatidic acid pathway mediates mesenchymal cell recruitment and fibrotic contraction in lung transplant fibrosis.
Topics: Adult; Aged; Biomarkers; Bronchoalveolar Lavage Fluid; Cell Movement; Collagen; Female; Follow-Up Studies; Humans; Lung; Lung Transplantation; Lysophospholipids; Male; Mesenchymal Stem Cells; Middle Aged; Pulmonary Fibrosis; Transplant Recipients | 2021 |
A blocking peptide stabilizes lysophosphatidic acid receptor 1 and promotes lysophosphatidic acid-induced cellular responses.
Topics: Animals; Cell Line; Humans; Lysophospholipids; MAP Kinase Signaling System; Mice; Nedd4 Ubiquitin Protein Ligases; Proteasome Endopeptidase Complex; Proteolysis; Pulmonary Fibrosis; Receptors, Lysophosphatidic Acid; Ubiquitin | 2021 |
[The clinical study on the correlation of lysophosphatidic acid and vascular endotheli growth factor and endothelin in serum of pneumoconiosis].
Topics: Anthracosis; Coal Mining; Dust; Endothelins; Enzyme-Linked Immunosorbent Assay; Humans; Lysophospholipids; Occupational Diseases; Occupational Exposure; Pneumoconiosis; Pulmonary Fibrosis; Vascular Endothelial Growth Factor A | 2017 |
Lysophosphatidic acid accelerates lung fibrosis by inducing differentiation of mesenchymal stem cells into myofibroblasts.
Topics: Animals; Bleomycin; Cell Differentiation; Cells, Cultured; Humans; Isoxazoles; Lysophospholipids; Mesenchymal Stem Cells; Mice; Mice, Inbred ICR; Mice, SCID; Mice, Transgenic; Myofibroblasts; Propionates; Pulmonary Fibrosis; Receptors, Lysophosphatidic Acid; Signal Transduction | 2014 |
Transforming growth factor-Beta inhibits heme oxygenase-1 expression in lung fibroblast through nuclear factor-kappa-B-dependent pathway.
Topics: Animals; Blotting, Western; Cell Differentiation; Fibroblasts; Gene Expression Regulation; Gene Knockdown Techniques; Heme Oxygenase-1; Humans; Lung; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pulmonary Fibrosis; Transcription Factor RelA; Transforming Growth Factor beta | 2014 |
Transforming growth factor β regulates β-catenin expression in lung fibroblast through NF-κB dependent pathway.
Topics: Animals; beta Catenin; Bleomycin; Cell Differentiation; Cell Line; Fibroblasts; Humans; Lung; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Pulmonary Fibrosis; Transforming Growth Factor beta; Up-Regulation | 2014 |
Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.
Topics: Animals; Antibiotics, Antineoplastic; Benzoates; Bleomycin; Gene Expression Regulation; Lung; Lung Injury; Lysophospholipids; Mice; Mice, Inbred C57BL; Phosphoric Diester Hydrolases; Pulmonary Fibrosis | 2016 |
Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis.
Topics: Allografts; Animals; Autocrine Communication; beta Catenin; Bronchiolitis Obliterans; Cells, Cultured; Collagen; Female; Graft Rejection; Humans; Lung; Lung Transplantation; Lysophospholipids; Male; Mice, Inbred C57BL; Mice, Inbred DBA; NFATC Transcription Factors; Phosphoric Diester Hydrolases; Pulmonary Fibrosis; Receptors, Lysophosphatidic Acid; Transcriptional Activation | 2017 |
The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury.
Topics: Animals; Anoikis; Apoptosis; Bleomycin; Caspase 3; Cell Adhesion; Cells, Cultured; Disease Models, Animal; Epithelial Cells; Fibroblasts; Humans; Lung; Lung Injury; Lysophospholipids; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Pulmonary Fibrosis; Rats; Receptors, Lysophosphatidic Acid; Signal Transduction; Time Factors | 2012 |
PRR5L degradation promotes mTORC2-mediated PKC-δ phosphorylation and cell migration downstream of Gα12.
Topics: Amino Acid Motifs; Animals; Apoptosis Regulatory Proteins; Bleomycin; Cell Movement; Disease Models, Animal; Enzyme Activation; Enzyme Stability; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; GTP-Binding Protein alpha Subunits, G12-G13; HEK293 Cells; Humans; Intracellular Signaling Peptides and Proteins; Lung; Lysophospholipids; Mechanistic Target of Rapamycin Complex 2; Mice; Mice, Inbred C57BL; Mice, Knockout; Multiprotein Complexes; Phosphorylation; Protein Kinase C-delta; Protein Stability; Proteins; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; RNA Interference; Signal Transduction; Time Factors; TOR Serine-Threonine Kinases; Trans-Activators; Transfection; Ubiquitin-Protein Ligases; Ubiquitination | 2012 |
The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.
Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Female; Fibroblasts; Leukocytes; Lung; Lung Injury; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Biological; Pulmonary Fibrosis; Receptors, Lysophosphatidic Acid | 2008 |
From lung injury to fibrosis.
Topics: Animals; Fibroblasts; Fibrosis; Humans; Lung; Lung Diseases; Lung Injury; Lysophospholipids; Macrophages; Models, Biological; Pulmonary Alveoli; Pulmonary Fibrosis; Receptors, Lysophosphatidic Acid | 2008 |